Hikma Bond
The status, timeline and source of this project. A free account opens every field.
Source: International Finance Corporation (IFC)
Hikma Pharmaceuticals PLC (“Hikma” or the “Company” or together with its subsidiaries “the Group”) is a pharmaceutical company incorporated in the United Kingdom (UK) and listed on the London Stock Exchange. While the Group was founded in Jordan in 1978, Hikma has expanded its footprint with successful operations across the Middle East and North Africa (MENA) region, North America and Europe with
- Status
- Prospective
- Sector
- Commercial, Warehouse, Manufacturing (Industrial), Road, Government, Hospital
- Location
- Jordan
- Updated
- 22 Jul 2026
- Source
- International Finance Corporation (IFC)
ConstructChat
Ask ConstructChat about Hikma Bond
Pick a question to edit it, or write your own.
First answer free · no account
Project Information FAQ
Project Information
Participants
Sponsoring Agency |
Status
Original status | active |
Taiyo status | Prospective |
Taiyo last update | 2026-07-22 |
Contact
| Not available for this record. |
Description
Description | Hikma Pharmaceuticals PLC (“Hikma” or the “Company” or together with its subsidiaries “the Group”) is a pharmaceutical company incorporated in the United Kingdom (UK) and listed on the London Stock Exchange. While the Group was founded in Jordan in 1978, Hikma has expanded its footprint with successful operations across the Middle East and North Africa (MENA) region, North America and Europe with 29 manufacturing plants in 10 countries. Hikma is a long-standing IFC client since 1987 whereby support was primarily provided for the Company’s investments in the MENA region.IFC provided a financing package (the “Financing Package”) to Hikma Finance USA LLC (the “Borrower”), a wholly owned subsidiary of Hikma. Proceeds of the IFC Loan (as defined below) and the Bond (as defined below) which, for the avoidance of doubt, is limited to IFC’s subscription of US$50 million in the Bond, will be used to support the Company’s general corporate purposes including acquisitions, capital expenditure, working capital needs, and any investment in research and development in the Middle East region, as well as debt refinancing of the Group (the “Project”). |
Original sector | G-FA - Pharmaceuticals and Medicine Manufacturing |
Budget |
Location
Country | Jordan |
Source
Source | International Finance Corporation (IFC) |
URL |
More Details
Record type | Project |
Sector | Commercial, Warehouse, Manufacturing (Industrial), Road, Government, Hospital |
Article published date | 2025-09-10 |
Research
Free account
View all details
You are reading the public part. A free account opens the rest:
- Every detail on this project
- News and media coverage
- Technical research
Free account · no card · lands you back on this project
